Skip to content

To investigate the effect of constipation on the clinical efficacy of WMT in patients with autism

To investigate the effect of constipation on the clinical efficacy of WMT in patients with autism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094256
Enrollment
Unknown
Registered
2024-12-19
Start date
2024-12-31
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorder

Interventions

No constipation group:NA
The constipation group:NA
TCM empirical constipation group:NA
TCM deficiency syndrome constipation group:NA

Sponsors

The First Afiliated Hospital of Guangdong Pharmaceutical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 18 Years

Inclusion criteria

Inclusion criteria: Select ASD patients who have received two or more WMT treatments in the Department of Gastroenterology of The First Afiliated Hospital of Guangdong Pharmaceutical University from January 2020 to March 2026.Inclusion criteria: (1) age of 2-18 years at baseline, excluding cutoff values; (2) no gender limitation; (3) confirmed diagnosis of childhood autism according to Autism Diagnostic Interview Revised (ADI-R) and DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, fifth edition; APA2013); (4) no washing fecal microbiota transplantation before; (5) cooperate with the examination and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) taking antibiotics or probiotics within 1 month before WMT; (2) diagnosed with inflammatory bowel disease, gastrointestinal cancer, celiac disease and other gastrointestinal diseases requiring urgent treatment; (3) Diagnosed with severe heart, brain, lung, liver, or kidney disease.

Design outcomes

Primary

MeasureTime frame
Autism Behavior Checklist, ABC;Childhood Autism RatingScale,CARS;Sleep Disturbance Scale for Children,SDSC;Bristol Stool Scale;

Secondary

MeasureTime frame
Cell endotoxins;D-lactic acid;diamine oxidase;Gastrin-17;Interleukin-6;white blood cell;

Countries

China

Contacts

Public ContactWu Lihao

The First Afiliated Hospital of Guangdong Pharmaceutical University

wulihao888@126.com+86 136 6063 5861

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026